Catalyst Wire Dossier Catalyst Wire Dossier

boosted darunavir + dolutegravir

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for boosted darunavir + dolutegravir, covering 2023-11-29 to 2023-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Dual Therapy With Boosted Darunavir + Dolutegravir [Phase 3]

See pricing